Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System

Ítems similars

• Chemical leukoderma following application of transdermal methylphenidate patch
  per: Ghasri, Pedram, et al.
  Publicat: (2012)
• Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System
  per: Jones, S. Christopher, et al.
  Publicat: (2015)
• Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017
  per: Dores, Graça M., et al.
  Publicat: (2019)
• Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration’s Adverse Event Reporting System from 2016 to 2021
  per: Christine Learned, BA, et al.
  Publicat: (2022-06-01)
• Review of Reported Clinical Information System Adverse Events in US Food and Drug Administration Databases
  per: Myers, R.B., et al.
  Publicat: (2011)